AstraZeneca’s Koselugo (selumetinib) has secured a positive recommendation from the European...
NEWS
SAR446268 Earns US Fast Track Designation for Non-Congenital...
Sanofi is pleased to announce that the US Food and Drug Administration (FDA) has granted Fast Track...
Enhertu plus pertuzumab granted FDA Priority Review as potential...
AstraZeneca and Daiichi Sankyo have announced that the US Food and Drug Administration (FDA) has...
Johnson & Johnson Reports Positive Phase 3 Results for...
Johnson & Johnson has released new Phase 3 clinical trial data showing that icotrokinra, a...